EMA's Proposal To Disclose Key Elements Of Pediatric Plans On Hold For Now

Business Pro Con_1200
EMA Is Still Weighing Up The Implications Of Its PIP Transparency Proposal • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D